Novanta Inc Cash Flow Conversion Efficiency
Novanta Inc cash flow conversion efficiency. Based on the latest financial reports, Novanta Inc (NOVT) has a cash flow conversion efficiency ratio of 0.041x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($66.23 Million) by net assets ($1.62 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Novanta Inc (1998–2025)
Cash flow conversion efficiency of Novanta Inc from 1998 to 2025. This chart illustrates how Novanta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Novanta Inc stock quote for real-time trading data and today's change.
Novanta Inc Cash Flow Conversion Ratio Explained
Novanta Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Novanta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novanta Inc ranked by their cash flow conversion efficiency. Also see Novanta Inc market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TEMENOS AG UNSP.ADR/1
F:TE8A
|
0.282x |
|
LB Group Co Ltd
SHE:002601
|
0.037x |
|
Almonty Industries Inc
AU:AII
|
-0.035x |
|
Intercorp Financial Services Inc
NYSE:IFS
|
-0.008x |
|
Hunan Yuneng New Energy Battery Material Co. Ltd. A
SHE:301358
|
N/A |
|
Sprouts Farmers Market LLC
NASDAQ:SFM
|
0.089x |
|
Bank of Ayudhya Public Company Limited
F:NVAU
|
0.070x |
|
Zalando SE
XETRA:ZAL
|
-0.162x |
Annual Cash Flow Conversion Efficiency for Novanta Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Novanta Inc from 1998 to 2025. Review NOVT FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.31 Billion | $64.06 Million | 0.049x | -77.07% |
| 2024-12-31 | $745.70 Million | $158.51 Million | 0.213x | +19.22% |
| 2023-12-31 | $673.46 Million | $120.08 Million | 0.178x | +13.44% |
| 2022-12-31 | $577.59 Million | $90.78 Million | 0.157x | -13.41% |
| 2021-12-31 | $521.29 Million | $94.62 Million | 0.182x | -38.28% |
| 2020-12-31 | $476.81 Million | $140.24 Million | 0.294x | +94.00% |
| 2019-12-31 | $417.17 Million | $63.25 Million | 0.152x | -37.72% |
| 2018-12-31 | $368.25 Million | $89.65 Million | 0.243x | +37.69% |
| 2017-12-31 | $358.47 Million | $63.38 Million | 0.177x | -4.23% |
| 2016-12-31 | $258.87 Million | $47.79 Million | 0.185x | +35.18% |
| 2015-12-31 | $244.70 Million | $33.42 Million | 0.137x | -31.78% |
| 2014-12-31 | $211.25 Million | $42.29 Million | 0.200x | -1.37% |
| 2013-12-31 | $242.40 Million | $49.20 Million | 0.203x | +62.92% |
| 2012-12-31 | $228.21 Million | $28.43 Million | 0.125x | -42.26% |
| 2011-12-31 | $209.36 Million | $45.17 Million | 0.216x | +469.40% |
| 2010-12-31 | $81.12 Million | $-4.74 Million | -0.058x | -122.96% |
| 2009-12-31 | $152.90 Million | $38.90 Million | 0.254x | 0.00% |
| 2008-12-31 | $152.90 Million | $38.90 Million | 0.254x | +88.84% |
| 2007-12-31 | $278.24 Million | $37.49 Million | 0.135x | +31.11% |
| 2006-12-31 | $343.07 Million | $35.26 Million | 0.103x | +547.68% |
| 2005-12-31 | $306.56 Million | $4.86 Million | 0.016x | -86.30% |
| 2004-12-31 | $305.56 Million | $35.40 Million | 0.116x | +38.41% |
| 2003-12-31 | $260.79 Million | $21.83 Million | 0.084x | +81.78% |
| 2002-12-31 | $254.48 Million | $11.72 Million | 0.046x | +174.37% |
| 2001-12-31 | $282.33 Million | $-17.48 Million | -0.062x | -75.22% |
| 2000-12-31 | $289.27 Million | $-10.22 Million | -0.035x | -37.87% |
| 1999-12-31 | $171.70 Million | $-4.40 Million | -0.026x | +55.74% |
| 1998-12-31 | $120.90 Million | $-7.00 Million | -0.058x | -- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more